Abstract
The research assesses the impact of factors on financial risk of listed pharmaceutical companies in Vietnam. The study used a secondary data set from the financial statements of pharmaceutical companies listed in Vietnam stock market for the period from 2009 to 2021 combined with methods of analyzing static panel data and performing tests model selection. The research shows that enterprises have low debt structure; large solvency, profitability, operational efficiency, capital structure, enterprise size; long- term existence, the level of financial risk is low. The paper results are basically consistent with financial risk theory and related studies. The study makes recommendations to minimize the level of financial risk of enterprises in the survey sample.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
